volume 7, issue 11, P964-973 2015
DOI: 10.18632/aging.100843
View full text
Sign up to set email alerts

Abstract: Rapamycin has been shown to extend lifespan in rodent models, but the effects on metabolic health and function have been widely debated in both clinical and translational trials. Prior to rapamycin being used as a treatment to extend both lifespan and healthspan in the human population, it is vital to assess the side effects of the treatment on metabolic pathways in animal model systems, including a closely related non-human primate model. In this study, we found that long-term treatment of marmoset monkeys wi…

Expand abstract